| 2024-08-14 | -36.9% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.17, revenue of $99M misses by $4.31M |
| 2023-08-30 | +36.2% | legal | SEC EDGAR | TOI 8-K: 8.01 (SEC Filing) |
| 2023-11-08 | +35.8% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2024-11-14 | -29.9% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript |
| 2026-03-13 | +29.7% | earnings | Seeking Alpha | TOI reiterates 2026 revenue guidance of $630M–$650M while expanding delegated capitation partnerships |
| 2026-03-13 | +29.7% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q4 2025 Earnings Call Transcript |
| 2026-03-13 | +29.7% | news | Benzinga | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2023-06-15 | +26.6% | legal | SEC EDGAR | TOI 8-K: 8.01 and (SEC Filing) |
| 2023-03-09 | -25.5% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2026-03-16 | +25.1% | news | Stock Titan | Chernett Amends 13G; Holds 10.23% of Oncology Institute (TOI) - Stock Titan |
| 2025-05-15 | +25.0% | earnings | Seeking Alpha | TOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growth |
| 2025-05-15 | +25.0% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call Transcript |
| 2025-03-24 | +24.5% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.14, revenue of $100.27M |
| 2025-03-24 | +24.5% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2025-03-24 | +24.5% | earnings | Stock Titan | Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - Stock Titan |
| 2022-03-11 | +24.3% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-25 | +23.8% | news | The Motley Fool | Oncology Institute - TOI - Stock Price & News - The Motley Fool |
| 2025-11-14 | +23.4% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.14 misses by $0.03, revenue of $136.6M beats by $13.97M |
| 2025-11-14 | +23.4% | earnings | Seeking Alpha | TOI raises 2025 revenue outlook to $495M-$505M as pharmacy growth accelerates and adjusted EBITDA turns positive |
| 2025-11-14 | +23.4% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q3 2025 Earnings Call Transcript |
| 2024-05-14 | -23.0% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.22 |
| 2024-05-14 | -23.0% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2023-06-12 | -22.5% | legal | SEC EDGAR | TOI 8-K: 5.02 and 7.01 (SEC Filing) |
| 2023-06-14 | +22.3% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-02 | +20.7% | earnings | Zacks Investment Research | What date does The Oncology Institute's (TOI) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2026-03-15 | +19.1% | earnings | timothysykes.com | B. Riley Ups TOI Price Target Amidst Positive Earnings Outlook - timothysykes.com |
| 2026-03-14 | +19.1% | analyst | StocksToTrade | B. Riley’s Price Target Boost Signals Growth for Oncology Institute - StocksToTrade |
| 2021-11-15 | -18.5% | news | Stock Titan | Latest TOI News - The Oncology Institute Achieves $1.8 Million... - Stock Titan |
| 2024-11-13 | -18.4% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.18, revenue of $99.9M |
| 2024-11-13 | -18.4% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2022-04-04 | +17.5% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-11-13 | +17.4% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2025-11-13 | +17.4% | earnings | Yahoo Finance | The Oncology Institute, Inc. (TOI) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2025-11-13 | +17.4% | earnings | GlobeNewswire | The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance - GlobeNewswire |
| 2022-03-07 | -17.1% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-11-22 | -16.5% | legal | SEC EDGAR | TOI 8-K: 1.01, 2.01 (SEC Filing) |
| 2026-01-12 | -15.5% | earnings | Seeking Alpha | The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue |
| 2026-01-12 | -15.5% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | -15.5% | earnings | Stock Titan | Cancer care group projects growth and first full year of adjusted profit - Stock Titan |
| 2026-02-25 | +15.2% | executive | Stock Titan | Oncology Institute CEO, CFO to speak at three March investor events - Stock Titan |
| 2025-05-14 | +14.1% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2021-11-18 | -14.0% | legal | SEC EDGAR | TOI 8-K: 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 8.01 (SEC Filing) |
| 2021-11-18 | -14.0% | news | Zacks Investment Research | Should I buy The Oncology Institute (TOI) - Zacks Investment Research |
| 2023-03-08 | -13.3% | news | ChartMill | TOI Technical Analysis | Trend, Signals & Chart Patterns | ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) - ChartMill |
| 2025-02-26 | +12.9% | legal | SEC EDGAR | TOI 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-04-11 | +12.6% | legal | SEC EDGAR | TOI 8-K: 8.01 and (SEC Filing) |
| 2022-11-09 | -12.6% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | -12.3% | news | simplywall.st | Both individual investors who control a good portion of The Oncology Institute, Inc. (NASDAQ:TOI) along with institutions must be dismayed after last week's 13% decrease - simplywall.st |
| 2022-05-11 | -11.8% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-09 | -11.5% | news | Yahoo Finance | Is Oncology Institute (TOI) Quietly Rewiring Its Edge Around AI Talent And Boardroom Financial Discipline? - Yahoo Finance |
| 2026-01-09 | -11.5% | executive | Quiver Quantitative | The Oncology Institute Announces Promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer - Quiver Quantitative |
| 2023-03-17 | -11.5% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2026-01-05 | +11.3% | executive | Stock Titan | Cancer care group adds veteran CFO to its board of directors - Stock Titan |
| 2023-08-09 | -11.2% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2025-08-13 | -11.1% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2025-08-13 | -11.1% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-30 | +10.9% | news | Yahoo Finance | Why The Oncology Institute, Inc. (TOI) is Surging in 2025 - Yahoo Finance |
| 2025-05-07 | +10.8% | legal | SEC EDGAR | TOI 8-K: 5.02 and (SEC Filing) |
| 2022-08-16 | +10.7% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-25 | -10.7% | news | Stock Titan | TOI Stock Price, News & Analysis - Stock Titan |
| 2022-08-10 | +9.5% | legal | SEC EDGAR | TOI 8-K: 1.01, 2.03, 3.02, 7.01 (SEC Filing) |
| 2024-08-13 | -9.2% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q2 2024 Earnings Call Transcript |
| 2024-08-13 | -9.2% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2022-08-09 | +8.9% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2021-11-17 | -8.9% | news | TradingView | Technical Analysis of The Oncology Institute, Inc. (NASDAQ:TOI) - TradingView |
| 2023-03-27 | -8.3% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-22 | +8.1% | earnings | Quiver Quantitative | The Oncology Institute, Inc. Announces Release Date for Q3 2025 Financial Results and Conference Call Details - Quiver Quantitative |
| 2025-10-22 | +8.1% | earnings | Stock Titan | The Oncology Institute (NASDAQ: TOI) sets earnings release and conference call for Nov. 13 - Stock Titan |
| 2025-08-14 | -8.1% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.15 misses by $0.03, revenue of $119.8M beats by $6.63M |
| 2025-08-14 | -8.1% | earnings | Seeking Alpha | The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41% |
| 2025-08-14 | -8.1% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q2 2025 Earnings Call Transcript |
| 2025-06-06 | -7.9% | news | Seeking Alpha | The Oncology Institute files for $50M common stock offering |
| 2026-04-13 | +7.5% | news | GlobeNewswire | The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement |
| 2026-04-13 | +7.5% | news | Stock Titan | Cancer care model cut Medicare costs $6,400 per episode at TOI - Stock Titan |
| 2026-04-13 | +7.5% | news | Stock Titan | Oncology Institute (NASDAQ: TOI) 10% owner buys 20,000 shares in open market - Stock Titan |
| 2026-04-13 | +7.5% | news | Investing.com | Chernett Jorey buys oncology institute (TOI) shares worth $62000 - Investing.com |
| 2026-04-13 | +7.5% | earnings | MarketBeat | Insider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Buys 20,000 Shares of Stock - MarketBeat |
| 2024-03-27 | -7.3% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q4 2023 Earnings Call Transcript |
| 2024-03-27 | -7.3% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.21, revenue of $86M beats by $3.96M |
| 2024-03-27 | -7.3% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2026-03-31 | +7.3% | news | Simply Wall St. | One Oncology Institute Insider Raised Their Stake In The Previous Year |
| 2022-05-05 | -6.8% | legal | SEC EDGAR | TOI 8-K: 5.02 (SEC Filing) |
| 2025-11-12 | -6.7% | earnings | Yahoo Finance | Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q3 2025 Result - Yahoo Finance |
| 2026-03-17 | +6.7% | earnings | Motley Fool | Oncology Institute (TOI) Earnings Transcript |
| 2026-03-17 | +6.7% | news | Investing.com | Chernett Jorey buys oncology institute (TOI) shares worth $1.2m - Investing.com |
| 2025-08-19 | -6.6% | legal | Seeking Alpha | The Oncology Institute: A Promising Company In A Growing Sector |
| 2025-08-19 | -6.6% | legal | Seeking Alpha | The Oncology Institute: A Promising Company In A Growing Sector (NASDAQ:TOI) - Seeking Alpha |
| 2022-05-12 | +6.6% | legal | SEC EDGAR | TOI 8-K: 8.01 (SEC Filing) |
| 2026-03-23 | -6.4% | news | Stock Titan | Major holder Chernett adds 25,000 Oncology Institute (NASDAQ: TOI) shares - Stock Titan |
| 2021-11-24 | +6.3% | news | TradingView | The Oncology Institute, Inc. Income Statement – NASDAQ:TOI - TradingView |
| 2026-04-23 | -5.9% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | TOI (The Oncology Institute Inc.) Q4 2025 EPS outperforms projections, shares rise 3.21 percent on positive investor sentiment. - Sector Underperform - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -5.9% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | TOI (The Oncology Institute Inc.) Q4 2025 EPS beats estimates, shares gain 1.48 percent on favorable investor reaction. - Distressed Pick - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-12-01 | -5.5% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-01 | -5.5% | news | Stock Titan | Oncology Institute (NASDAQ: TOI) starts search to replace Gabe Ling on board - Stock Titan |
| 2025-05-05 | -5.4% | news | Yahoo Finance | The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24% - Yahoo Finance |
| 2022-11-15 | -5.3% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-10 | +5.2% | news | GlobeNewswire | Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings |
| 2026-03-12 | +5.0% | earnings | Seeking Alpha | The Oncology Institute GAAP EPS of -$0.06 beats by $0.03, revenue of $141.96M beats by $2.17M |
| 2026-03-12 | +5.0% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | +5.0% | earnings | Quiver Quantitative | The Oncology Institute (TOI) Stock Rises on Q4 2025 Earnings - Quiver Quantitative |
| 2026-03-12 | +5.0% | earnings | Investing.com | Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises - Investing.com |
| 2026-03-12 | +5.0% | news | Stock Titan | Cancer clinic network aims for positive adjusted EBITDA in 2026 - Stock Titan |
| 2026-03-12 | +5.0% | earnings | ChartMill | The Oncology Institute Inc. (NASDAQ:TOI) Beats Q4 2025 Estimates and Guides for 2026 Profitability - ChartMill |
| 2026-03-12 | +5.0% | earnings | GlobeNewswire | The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - GlobeNewswire |
| 2026-03-12 | +5.0% | earnings | MarketBeat | Oncology Institute Q4 2025 Earnings Call Transcript - MarketBeat |
| 2026-01-07 | +4.7% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-07 | +4.7% | news | simplywall.st | For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move - simplywall.st |
| 2024-05-18 | -4.7% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q1 2024 Earnings Call Transcript |
| 2022-12-01 | +4.4% | legal | SEC EDGAR | TOI 8-K: 5.02 (SEC Filing) |
| 2023-04-05 | -4.3% | news | CoinCodex | The Oncology Institute, Inc. (TOI) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2025-05-06 | +4.2% | news | Seeking Alpha | The Oncology Institute: Insiders Buy Up Big While Valuations Are Murky |
| 2025-05-06 | +4.2% | news | Seeking Alpha | The Oncology Institute: Insiders Buy Up Big While Valuations Are Murky (NASDAQ:TOI) - Seeking Alpha |
| 2026-04-22 | -4.2% | earnings | UBND thành phố Hải Phòng | TOI (The Oncology Institute Inc.) Q4 2025 EPS outperforms projections, shares rise 3.21 percent on positive investor sentiment. - EBITDA Margin - UBND thành phố Hải Phòng |
| 2026-04-22 | -4.2% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | TOI (The Oncology Institute Inc.) reports a narrower than projected Q4 2025 loss, beating consensus EPS estimates by 34 percent. - Expansion Phase - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-22 | -4.2% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | TOI (The Oncology Institute Inc.) reports a narrower than projected Q4 2025 loss, beating consensus EPS estimates by 34 percent. - Stock Trading Network - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-09-18 | -4.1% | legal | SEC EDGAR | TOI 8-K: 8.01 and (SEC Filing) |
| 2022-03-10 | -4.0% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-08-17 | +4.0% | news | ChartMill | TOI Stock Price, Quote & Chart | ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) - ChartMill |
| 2026-04-15 | +3.7% | news | GlobeNewswire | Topicus.com Inc. Announces Release Date for First Quarter Results |
| 2025-09-18 | +3.7% | news | Yahoo Finance | The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance |
| 2025-03-27 | -3.5% | earnings | Seeking Alpha | The Oncology Institute reports Q4 results |
| 2025-03-27 | -3.5% | legal | SEC EDGAR | TOI 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-04-20 | -3.4% | news | Insider Monkey | Here’s What Powered The Oncology Institute’s (TOI) Gains |
| 2026-04-20 | -3.4% | news | Yahoo Finance | Here’s What Powered The Oncology Institute’s (TOI) Gains - Yahoo Finance |
| 2023-05-10 | +2.8% | legal | SEC EDGAR | TOI 8-K: 2.02 and (SEC Filing) |
| 2023-09-01 | +2.8% | legal | SEC EDGAR | TOI 8-K: 5.02 (SEC Filing) |
| 2026-04-06 | +2.7% | executive | GlobeNewswire | The Oncology Institute Names Minh Merchant Chief Legal Officer |
| 2026-04-06 | +2.7% | news | Stock Titan | Oncology Institute taps veteran healthcare lawyer as it scales - Stock Titan |
| 2026-04-06 | +2.7% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is The (TOI) Stock Volatile Now | Price at $3.21, Up 2.88% - Retail Money Flow - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-06 | +2.7% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is The (TOI) Stock Volatile Now | Price at $3.21, Up 2.88% - Gamma Alerts - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-10-12 | +2.7% | news | Yahoo Finance | While institutions own 36% of The Oncology Institute, Inc. (NASDAQ:TOI), retail investors are its largest shareholders with 47% ownership - Yahoo Finance |
| 2026-04-03 | +2.4% | news | Simply Wall St. | TSX Stocks Including Montage Gold That May Be Trading Below Intrinsic Value Estimates |
| 2026-04-03 | +2.4% | news | Cổng thông tin điện tử tỉnh Tây Ninh | TOI Stock Analysis: The Oncology Institute Inc. Holds $3.12 Level After Minor Daily Dip - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-09-06 | -2.4% | legal | SEC EDGAR | TOI 8-K: 5.02 (SEC Filing) |
| 2026-03-11 | +2.0% | earnings | GuruFocus | The Oncology Institute Inc (TOI) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus |
| 2023-08-10 | -2.0% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-05-04 | +2.0% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for The Oncology Institute (TOI) - Zacks Investment Research |
| 2026-04-14 | +1.9% | legal | Stock Titan | [144] Oncology Institute, Inc. SEC Filing - Stock Titan |
| 2025-05-27 | +1.8% | news | Intellectia AI | TOI Forecast — Price Prediction for 2026. Should I Buy TOI? - Intellectia AI |
| 2024-11-12 | +1.8% | legal | SEC EDGAR | TOI 8-K: 5.02 and (SEC Filing) |
| 2026-04-16 | +1.7% | earnings | MarketBeat | Mohit Kaushal Sells 38,433 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat |
| 2026-04-16 | +1.7% | news | Stock Titan | Director at Oncology Institute (TOI) trims stake via planned share sales - Stock Titan |
| 2024-03-03 | -1.6% | news | Seeking Alpha | Jefferies cautious on Value Based Care providers; favors ASTH, PRVA, TOI |
| 2024-04-03 | -1.5% | legal | SEC EDGAR | TOI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-25 | -1.5% | earnings | Seeking Alpha | The oncology institute targets profitability and $460M-$480M revenue in 2025 |
| 2025-03-25 | -1.5% | earnings | Seeking Alpha | The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript |
| 2025-03-25 | -1.5% | legal | SEC EDGAR | TOI 8-K: 1.01, 3.02, 3.03, 5.03, 7.01 (SEC Filing) |
| 2022-09-22 | -1.3% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-05-22 | -1.2% | legal | SEC EDGAR | TOI 8-K: 5.02 (SEC Filing) |
| 2024-09-23 | -1.2% | executive | Seeking Alpha | The Oncology Institute announces Rob Carter as CFO |
| 2024-09-23 | -1.2% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-09 | -1.2% | news | GlobeNewswire | The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference |
| 2026-04-09 | -1.2% | executive | Stock Titan | Cancer care company CEO, CFO join virtual Needham event April 15 - Stock Titan |
| 2026-03-30 | +1.2% | news | Investing.com | Oncology institute (TOI) ten percent owner Chernett buys $81,189 in stock - Investing.com |
| 2026-03-30 | +1.2% | news | Stock Titan | Insider at Oncology Institute (TOI) buys 27,429 company shares - Stock Titan |
| 2021-12-06 | -1.1% | earnings | MarketBeat | Oncology Institute (TOI) Stock Price, News & Analysis $TOI - MarketBeat |
| 2021-12-06 | -1.1% | earnings | MarketBeat | Top Oncology Institute (TOI) Competitors 2026 - MarketBeat |
| 2026-02-02 | +1.1% | news | simplywall.st | Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding - simplywall.st |
| 2026-02-23 | +1.1% | legal | SEC EDGAR | TOI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-02-23 | +1.1% | executive | Stock Titan | Pharmacy CEO Kim Tzoumakas joins board of large U.S. cancer care group - Stock Titan |
| 2026-04-01 | +0.8% | executive | Stock Titan | RSU grant boosts Oncology Institute (NASDAQ: TOI) admin chief stake - Stock Titan |
| 2026-04-01 | +0.8% | news | Stock Titan | Oncology Institute (TOI) CMO gets 66,446-share RSU grant and tax sale - Stock Titan |
| 2026-04-01 | +0.8% | executive | Stock Titan | Oncology Institute (TOI) grants 70,270 RSUs to Chief Clinical Officer Langsam - Stock Titan |
| 2026-04-01 | +0.8% | executive | Stock Titan | Oncology Institute (TOI) CEO awarded 670K RSUs as issuer sells shares for taxes - Stock Titan |
| 2026-04-01 | +0.8% | executive | Stock Titan | Oncology Institute (TOI) CFO gets 202,914 RSUs, sells 20,320 shares for taxes - Stock Titan |
| 2021-06-29 | -0.6% | legal | SEC EDGAR | TOI 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-03-25 | +0.3% | legal | MT Newswires | Oncology Institute Insider Bought Shares Worth $388,750, According to a Recent SEC Filing |
| 2026-03-25 | +0.3% | news | Investing.com | Chernett Jorey buys oncology institute (TOI) shares worth $388,750 - Investing.com |
| 2025-09-05 | -0.3% | news | Investing.com | Oncology institute (TOI) shareholder sales total $20.7 million - Investing.com |
| 2025-12-18 | -0.2% | news | Seeking Alpha | The Oncology Institute: Making Progress |
| 2025-12-18 | -0.2% | news | Seeking Alpha | The Oncology Institute: Making Progress (NASDAQ:TOI) - Seeking Alpha |
| 2021-10-22 | -0.1% | legal | SEC EDGAR | TOI 8-K: 8.01 and (SEC Filing) |
| 2026-04-24 | — | news | Stock Titan | Oncology Institute (TOI) CAO Kristin England files Form 4 showing no insider trades - Stock Titan |
| 2026-04-24 | — | executive | Stock Titan | Oncology Institute (NASDAQ: TOI) chief files Form 4 with no trades - Stock Titan |